Millennium Management’s SAB Biotherapeutics SABS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,351
| Closed | -$22.1K | – | 4349 |
|
|
2025
Q1 | $22.1K | Sell |
16,351
-13,060
| -44% | -$17.6K | ﹤0.01% | 3878 |
|
|
2024
Q4 | $112K | Sell |
29,411
-22,535
| -43% | -$86.1K | ﹤0.01% | 3791 |
|
|
2024
Q3 | $140K | Sell |
51,946
-838
| -2% | -$2.26K | ﹤0.01% | 3801 |
|
|
2024
Q2 | $164K | Sell |
52,784
-1,266
| -2% | -$3.93K | ﹤0.01% | 3626 |
|
|
2024
Q1 | $245K | Buy |
+54,050
| New | +$245K | ﹤0.01% | 3590 |
|
|
2022
Q4 | – | Sell |
-3,855
| Closed | -$27K | – | 5146 |
|
|
2022
Q3 | $27K | Sell |
3,855
-2,567
| -40% | -$18K | ﹤0.01% | 4934 |
|
|
2022
Q2 | $93K | Buy |
+6,422
| New | +$93K | ﹤0.01% | 4722 |
|
|
2021
Q4 | – | Sell |
-19,131
| Closed | -$1.93M | – | 5566 |
|
|
2021
Q3 | $1.93M | Buy |
19,131
+15,465
| +422% | +$1.56M | ﹤0.01% | 3077 |
|
|
2021
Q2 | $365K | Buy |
+3,666
| New | +$365K | ﹤0.01% | 4381 |
|